<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:atom="http://www.w3.org/2005/Atom" version="2.0">
<channel>
    <atom:link href="https://news.vt.edu/tags/_jcr_content/search-results.xml/news_vt_edu:breast-cancer" rel="self" type="application/rss+xml"/>
    <title>Tags</title>
    <link>https://news.vt.edu/tags.html/news_vt_edu:breast-cancer</link>
    <description></description>
    <language>en</language>
    <managingEditor></managingEditor>
    <webMaster></webMaster>
    <docs>http://cyber.law.harvard.edu/rss/rss.html</docs>
    <item>
        <title>What is histotripsy and how does it work?</title>
        <link>https://news.vt.edu/videos/y/2025/02/HUm8dQ4Zm-U.html</link>
        <description><![CDATA[ On this episode of Engineering Explained… What is histotripsy? Where is histotripsy available? What are the side effects? Is it only for the liver? Can it be used in other applications? Eli Vlaisavljevich provides his expertise on the fascinating field of non-invasive cancer therapy! While bubbles, clouds, and funny looking speakers may sound imaginary, histotripsy is the real deal. By using targeted ultrasound frequencies, it provides a friendlier alternative to the traditional radiation or surgical counterparts, creating a safe, highly precise tool for treating more than just cancer. Want to know more about what histotripsy is? See Eli&#39;s lab below: https://ultrasound-lab.beam.vt.edu/ ]]></description>
        <guid isPermaLink="true">https://news.vt.edu/videos/y/2025/02/HUm8dQ4Zm-U.html</guid>
		<video_url><![CDATA[https://youtube.com/watch?v=HUm8dQ4Zm-U]]></video_url>
<video_likes>218</video_likes>
<video_views>6168</video_views>
<video_length>2:53</video_length>
<video_upload_datetime>2025-02-12T12:30-0500</video_upload_datetime>

        <enclosure url="https://news.vt.edu/videos/y/2025/02/HUm8dQ4Zm-U.thumb.319.319.png" type="image/png"/>


        <category>Cancer Research</category><category>College of Engineering</category><category>Breast Cancer</category><category>Biomedical Engineering</category>
    </item>
    <item>
        <title>College of Engineering Outstanding Senior: Julia Riley</title>
        <link>https://news.vt.edu/videos/k/2024/05/1_p6tp089k.html</link>
        <description><![CDATA[ “My journey at Virginia Tech has been an incredibly fulfilling one, that continues to remind me that the unexpected parts of life can sometimes be the most rewarding” Julia Riley wouldn’t change a thing about her time at Virginia Tech. Her various research opportunities, connecting with women in STEM and her mom’s cancer diagnosis has continued to shape her career plans and fuel her passion for learning. ]]></description>
        <guid isPermaLink="true">https://news.vt.edu/videos/k/2024/05/1_p6tp089k.html</guid>
		<video_url><![CDATA[https://video.vt.edu/media/1_p6tp089k]]></video_url>

<video_views>581</video_views>
<video_length>2:02</video_length>
<video_upload_datetime>2024-05-06T10:31-0400</video_upload_datetime>

        <enclosure url="https://news.vt.edu/videos/k/2024/05/1_p6tp089k.thumb.319.319.png" type="image/png"/>


        <category>Breast Cancer</category><category>Honors and Awards</category><category>Student Life</category><category>Biological Systems Engineering</category><category>Campus Experience</category><category>Internships</category>
    </item>
    <item>
        <title>New study may inform chemotherapy approaches for breast cancer</title>
        <link>https://news.vt.edu/articles/2022/07/chemotherapy-to-treat-breast-cancer-may-aid-in-its-spread--virgi.html</link>
        <description><![CDATA[ In a first-of-its-kind finding, Virginia Tech researchers have found platinum-based chemotherapy drugs may activate a breast cancer patient’s lymphatic system and affect how tumor cells spread. But the drugs might be made more effective if the changes to the lymphatic system can be blocked or even reversed by an additional therapy. ]]></description>
        <pubDate>Mon, 08 Aug 2022 07:36:00 -0400</pubDate>
        <guid isPermaLink="true">https://news.vt.edu/articles/2022/07/chemotherapy-to-treat-breast-cancer-may-aid-in-its-spread--virgi.html</guid>
        <enclosure url="https://news.vt.edu/articles/2022/07/chemotherapy-to-treat-breast-cancer-may-aid-in-its-spread--virgi/_jcr_content/article-image.transform/l-medium/image.png" type="image/png"/>
    	<category>Cancer Research</category><category>Global Land Grant Impact</category><category>Health Sciences and Technology (Roanoke)</category><category>Research</category><category>Biomedical Engineering and Mechanics</category><category>Munson Lab</category><category>Fralin Biomedical Research Institute at VTC</category><category>Breast Cancer</category><category>Fralin Biomedical Research Institute Cancer Research Group</category><category>Roanoke, Va.</category>
    </item>
    <item>
        <title>Cancer Research Alliance forges new collaborations, strengthens research programs at inaugural retreat</title>
        <link>https://news.vt.edu/articles/2022/03/cancer-research-alliance-forges-new-collaborations--strengthens-.html</link>
        <description><![CDATA[ More than 100 cancer researchers from across Virginia Tech recently met at the first Cancer Research Alliance retreat hosted by the Fralin Biomedical Research Institute at VTC. ]]></description>
        <pubDate>Mon, 04 Apr 2022 08:58:00 -0400</pubDate>
        <guid isPermaLink="true">https://news.vt.edu/articles/2022/03/cancer-research-alliance-forges-new-collaborations--strengthens-.html</guid>
        <enclosure url="https://news.vt.edu/articles/2022/03/cancer-research-alliance-forges-new-collaborations--strengthens-/_jcr_content/article-image.transform/l-medium/image.jpg" type="image/jpeg"/>
    	<category>Top News</category><category>Virginia Tech Carilion School of Medicine</category><category>Research</category><category>Gourdie Lab</category><category>Faculty of Health Sciences</category><category>Fralin Biomedical Research Institute at VTC</category><category>Breast Cancer</category><category>Finkielstein Lab</category><category>Fralin Biomedical Research Institute Cancer Research Group</category><category>Friedlander News</category><category>Roanoke, Va.</category><category>Children&#39;s National Research &amp; Innovation Campus</category><category>Cancer Research</category><category>DC Area</category><category>Virginia-Maryland College of Veterinary Medicine</category><category>Health Sciences and Technology (Roanoke)</category><category>Children&#39;s National Hospital</category><category>Brain Cancer</category><category>Animal Cancer Care and Research Center</category>
    </item>
    <item>
        <title>Fralin Biomedical Research Institute biotech spin-out raises additional $305,000 in investments</title>
        <link>https://news.vt.edu/articles/2021/12/Acomhal-new-investments.html</link>
        <description><![CDATA[ With this wave of new grants and investments, Acomhal Research Inc. is nearing a million dollars in total funding toward development of a new therapeutic to fight drug-resistant cancers such as glioblastoma multiforme and metastatic disease including triple negative breast cancer. ]]></description>
        <pubDate>Mon, 20 Dec 2021 12:25:00 -0500</pubDate>
        <guid isPermaLink="true">https://news.vt.edu/articles/2021/12/Acomhal-new-investments.html</guid>
        <enclosure url="https://news.vt.edu/articles/2021/12/Acomhal-new-investments/_jcr_content/article-image.transform/l-medium/image.png" type="image/png"/>
    	<category>Industry Partnerships</category><category>Lamouille Lab</category><category>Center for Vascular and Heart Research</category><category>Research</category><category>Gourdie Lab</category><category>Fralin Biomedical Research Institute at VTC</category><category>Breast Cancer</category><category>Fralin Biomedical Research Institute Cancer Research Group</category><category>Roanoke, Va.</category><category>Cancer Research</category><category>Health Sciences and Technology (Roanoke)</category><category>Industry Partners</category><category>Brain Cancer</category>
    </item>
    <item>
        <title>The race against cancer’s clock: New study shows chronic jet lag impairs immune response, accelerates tumor growth</title>
        <link>https://news.vt.edu/articles/2020/10/the-race-against-cancer-s-clock--new-study-shows-that-chronic-je.html</link>
        <description><![CDATA[ A new study led by Carla Finkielstein, an associate professor at the Fralin Biomedical Research Institute at VTC, and Diego Golombek, a professor at the National University of Quilmes, reveals that chronic jet lag impedes the body’s immune system and also changes the tumor microenvironment, favoring tumor growth. ]]></description>
        <pubDate>Wed, 14 Oct 2020 14:00:00 -0400</pubDate>
        <guid isPermaLink="true">https://news.vt.edu/articles/2020/10/the-race-against-cancer-s-clock--new-study-shows-that-chronic-je.html</guid>
        <enclosure url="https://news.vt.edu/articles/2020/10/the-race-against-cancer-s-clock--new-study-shows-that-chronic-je/_jcr_content/article-image.transform/l-medium/image.jpg" type="image/jpeg"/>
    	<category>Cancer Research</category><category>Top News</category><category>Academy of Integrated Science</category><category>Nanoscience</category><category>Research</category><category>Biological Sciences</category><category>Faculty of Health Sciences</category><category>Fralin Biomedical Research Institute at VTC</category><category>Breast Cancer</category><category>College of Science</category><category>Finkielstein Lab</category><category>Fralin Biomedical Research Institute Cancer Research Group</category>
    </item>
    <item>
        <title>Researcher receives NIH grant to study noninvasive treatment for metastatic breast tumors</title>
        <link>https://news.vt.edu/articles/2020/08/Biomedical-engineering-and-mechanics-NIH-grant-metastatic-breast-cancer.html</link>
        <description><![CDATA[ The aim of this project is to develop a novel, noninvasive method that combines nanoparticles with ultrasound to selectively target and kill cancerous cells in the breast tissue.  ]]></description>
        <pubDate>Thu, 27 Aug 2020 08:53:00 -0400</pubDate>
        <guid isPermaLink="true">https://news.vt.edu/articles/2020/08/Biomedical-engineering-and-mechanics-NIH-grant-metastatic-breast-cancer.html</guid>
        <enclosure url="https://news.vt.edu/articles/2020/08/Biomedical-engineering-and-mechanics-NIH-grant-metastatic-breast-cancer/_jcr_content/article-image.transform/l-medium/image.jpg" type="image/jpeg"/>
    	<category>Cancer Research</category><category>Virginia-Maryland College of Veterinary Medicine</category><category>Research</category><category>Biomedical Engineering and Mechanics</category><category>Munson Lab</category><category>Fralin Biomedical Research Institute at VTC</category><category>College of Engineering</category><category>Breast Cancer</category><category>Focused Ultrasound</category>
    </item>
    <item>
        <title>Fralin Biomedical Research Institute biotech spin-off seeks potential breast cancer treatment</title>
        <link>https://news.vt.edu/articles/2020/07/fralin-biomedical-research-institute-biotech-spin-out-seeks-pote.html</link>
        <description><![CDATA[ Roanoke-based cancer research startup, Acomhal Research Inc., secured a $399,878 Small Business Technology Transfer grant to determine if a molecule that stalls the spread of invasive brain cancer stem cells can help treat aggressive forms of breast cancer. ]]></description>
        <pubDate>Tue, 28 Jul 2020 10:18:00 -0400</pubDate>
        <guid isPermaLink="true">https://news.vt.edu/articles/2020/07/fralin-biomedical-research-institute-biotech-spin-out-seeks-pote.html</guid>
        <enclosure url="https://news.vt.edu/articles/2020/07/fralin-biomedical-research-institute-biotech-spin-out-seeks-pote/_jcr_content/article-image.transform/l-medium/image.jpg" type="image/jpeg"/>
    	<category>Cancer Research</category><category>Industry Partnerships</category><category>Lamouille Lab</category><category>Center for Vascular and Heart Research</category><category>Research</category><category>Gourdie Lab</category><category>Fralin Biomedical Research Institute at VTC</category><category>Breast Cancer</category><category>Brain Cancer</category>
    </item></channel>
</rss>